XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact
The Pharma Data
JANUARY 17, 2021
Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. The Company is on the cusp of transformational change as product development programs advance from the laboratory to the clinic. Diagnostics.
Let's personalize your content